PTEN and prostate carcinoma: In prostate cancer, the frequent loss of PTEN and activation of mTORC1 leads to increased protein stability of S-adenosylmethionine decarboxylase 1 (AMD1), which catalyzes the production of dcSAM and facilitates polyamine biosynthesis (Zabala-Letona et al., 2017).